Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025
LONDON and NEW YORK, Nov. 20, 2024 /PRNewswire/ -- Renalytix plc (LSE: RENX) (OTCQB: RNLXY), an artificial intelligence-enabled in vitro...
Diagnostics
UniDoc Showcases H3 Health Cube in Italy
AI-equipped H3 Health Cube Displayed at the Annual Assembly of the National Association of Italian Municipalities VANCOUVER, BC / ACCESSWIRE...
OPKO Health to Participate in the Piper Sandler 36th Annual Healthcare Conference
MIAMI, Nov. 20, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in...
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFH
-- Achieved all co-primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies versus each...
Tata Elxsi, DENSO and AAtek Inaugurate ‘Robotics and Automation Innovation Lab’ in Frankfurt
FRANKFURT, Germany and BENGALURU, India, Nov. 20, 2024 /PRNewswire/ -- Tata Elxsi, a global leader in design and technology services,...
Labbit LIMS Enhances Commitment to Data Security and Privacy with SOC 2 Type II Certification
VICTORIA, BC, Nov. 20, 2024 /PRNewswire/ - Semaphore Solutions, creator of Labbit and a leader in laboratory informatics solutions, is...
Roche Canada Announces New Informatics Jobs in Ontario’s Life Sciences Sector
These jobs will propel the province towards being a global leader in biomanufacturing and life sciences MISSISSAUGA, ON, Nov. 19,...
Axtria Unveils New Benchmarking Study on Territory Design and Refinement for Life Sciences Companies
Reveals latest trends in territory alignment, balancing workloads, and enhancing sales effectiveness that can help reshape, inform, and modernize commercial...
Lindus Health Rolls Out “All-in-One Infectious Disease CRO” Bespoke to Clinical Trials for Infectious Disease Interventions
NEW YORK, Nov. 19, 2024 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life...
Aegis Ventures Adds Two Leading Health Systems to the Digital Consortium
UPMC Enterprises and Vanderbilt Health Join Robust and Strategic Alliance of Health Systems Working Together to Build and Deploy Healthtech...
Physiowell Approach: Personalized Care for Every Patient
DUBAI, UAE / ACCESSWIRE / November 19, 2024 / Located in the heart of Dubai, Physiowell has redefined physiotherapy by...
GHIT Fund Awarded Open Philanthropy Grant to Expand Funding Sources for Global Health R&D
TOKYO, Nov. 18, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund is pleased to announce that Open Philanthropy, a grantmaking...
Akumin and United Imaging Announce Multi-year, Multi-modality Strategic Alliance
Launching Flagship Plantation Imaging Location as First Center of Excellence PLANTATION, Fla., Nov. 18, 2024 /PRNewswire/ -Â Akumin is transforming its...
Lynx Dx Announces Medicare Coverage for MyProstateScore 2.0, Marking a Major Milestone in Prostate Cancer Risk Assessment
ANN ARBOR, Mich., Nov. 18, 2024 /PRNewswire/ --Â Lynx Dx, a leader in advanced diagnostic solutions for prostate cancer, is proud...
Lunit Announces Collaboration with AstraZeneca to Develop AI-Powered Digital Pathology Risk Assessment Tools for NSCLC
Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations SEOUL,...
datma Joins GOAL Consortium as a Key Industry Supporter, Advancing Innovation in Academic Genomics and Precision Medicine
BEAVERTON, Ore., Nov. 18, 2024 /PRNewswire/ --Â datma, a leading provider of federated Real-World Data platform and related analytical tools, today...
EW Healthcare Partners Announces Leadership Evolution
Dr. Petri Vainio to become Executive ChairmanDr. Evis Hursever to become CEOScott Barry to become COOMarty Sutter to become Founding...
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel...
Trinity Biotech Announces Q3 2024 Financial Results
Q3 2024 total revenue of $15.2 million grew +3% Y/Y based on strong demand and output in the TrinScreen HIV...
AGFA HealthCare Expands the Enterprise Imaging Platform to Cardiology at Zuckerberg San Francisco General Hospital
Breaking down the silos between departments opens up an exciting new level of efficiency, cost savings, communication, and faster, more...